Bernstein L, Yuan J M, Ross R K, Pike M C, Hanisch R, Lobo R, Stanczyk F, Gao Y T, Henderson B E
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90033.
Cancer Causes Control. 1990 Jul;1(1):51-8. doi: 10.1007/BF00053183.
To assess whether risk of breast cancer in young women is associated with differences in luteal-phase hormone production and to attempt to explain differences in risk of breast cancer of young Shanghai Chinese and Los Angeles white women, two concurrent case-control studies of serum hormone concentrations were conducted. Both studies were carefully controlled for the possible confounding effects of age, weight, height, pregnancy history, and day of the menstrual cycle, by individually matching cases and controls on these factors. Case eligibility was limited to women with localized breast cancer. Sixteen of 39 Shanghai breast-cancer cases were sampled prior to the histologic diagnosis of their disease. The remaining 23 Shanghai cases and all 42 Los Angeles cases were diagnosed, and treated by surgery only, at least six months prior to hormonal evaluation. All subjects were sampled on day 22 of the menstrual cycle. Overall, cases had 13.5% higher serum estradiol concentrations (p = 0.038) with a case-to-control excess of 16.6% in Shanghai subjects (p = 0.089) and 10.8% in Los Angeles subjects (p = 0.23). There were no appreciable differences in amounts of sex-hormone binding globulin between cases and controls. Cases had lower progesterone levels than controls, but the situation was reversed when the analysis was restricted to subjects with evidence of ovulation. Los Angeles controls had 20.6% greater estradiol concentrations than Shanghai controls (p = 0.036); adjustment for body weight accounted for only 25.7% of this difference.(ABSTRACT TRUNCATED AT 250 WORDS)
为评估年轻女性患乳腺癌的风险是否与黄体期激素分泌差异相关,并试图解释上海年轻中国女性与洛杉矶年轻白人女性患乳腺癌风险的差异,开展了两项关于血清激素浓度的同期病例对照研究。两项研究均通过在年龄、体重、身高、妊娠史和月经周期天数等因素上对病例和对照进行个体匹配,仔细控制了这些因素可能产生的混杂效应。病例入选仅限于患有局限性乳腺癌的女性。39例上海乳腺癌病例中有16例在疾病组织学诊断之前进行了采样。其余23例上海病例和所有42例洛杉矶病例在激素评估前至少六个月被诊断,且仅接受了手术治疗。所有受试者均在月经周期的第22天进行采样。总体而言,病例的血清雌二醇浓度高出13.5%(p = 0.038),上海受试者病例与对照的差值为16.6%(p = 0.089),洛杉矶受试者为10.8%(p = 0.23)。病例与对照之间的性激素结合球蛋白量没有明显差异。病例的孕酮水平低于对照,但当分析仅限于有排卵证据的受试者时,情况则相反。洛杉矶对照的雌二醇浓度比上海对照高20.6%(p = 0.036);对体重进行调整后,仅占该差异的25.7%。(摘要截短于250字)